Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
2,314,947
-
Share change
-
+2,302,496
-
Total reported value
-
$135,729,310
-
Price per share
-
$58.62
-
Number of holders
-
50
-
Value change
-
+$135,000,075
-
Number of buys
-
45
-
Number of sells
-
1
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2016
As of 30 Jun 2016,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,314,947 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, RAYMOND JAMES & ASSOCIATES, Lumina Fund Management LLC, Clal Insurance Enterprises Holdings Ltd, CREDIT SUISSE AG/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Raymond James Financial Services Advisors, Inc., BANK OF AMERICA CORP /DE/, and STUYVESANT CAPITAL MANAGEMENT.
This page lists
50
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.